Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

Alexander C J van Akkooi¹, Tina J Hieken², Elizabeth M Burton³, Charlotte Ariyan⁴, Paolo A Ascierto⁵, Salvatore V M A Asero⁶, Christian U Blank⁷, Matthew S Block², Genevieve M Boland⁸, Corrado Caraco⁵, Sydney Chng^{9

10

11}, B Scott Davidson¹², Joao Pedreira Duprat Neto¹³, Mark B Faries¹⁴, Jeffrey E Gershenwald³, Dirk J Grunhagen¹⁵, David E Gyorki¹⁶, Dale Han¹⁷, Andrew J Hayes¹⁸, Winan J van Houdt⁷, Giorgos C Karakousis¹⁹, Willem M C Klop⁷, Georgina V Long^{9

11

20

21}, Michael C Lowe²², Alexander M Menzies^{9

11

20

21}, Roger Olofsson Bagge²³, Thomas E Pennington^{9

11}, Piotr Rutkowski²⁴, Robyn P M Saw^{9

10

11}, Richard A Scolyer^{9

10

11}, Kerwin F Shannon^{9

11}, Vernon K Sondak²⁵, Hussein Tawbi³, Alessandro A E Testori²⁶, Mike T Tetzlaff²⁷, John F Thompson^{9

10

11

21}, Jonathan S Zager²⁵, Charlotte L Zuur^{7

28}, Jennifer A Wargo³, Andrew J Spillane^{9

11

20

21}, Merrick I Ross³; International Neoadjuvant Melanoma Consortium (INMC)

Affiliations

¹ Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. a.v.akkooi@nki.nl.
² Mayo Clinic, Rochester, MN, USA.
³ The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
⁵ Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
⁶ Azienda di Rilievo Nazionale e di Alta Specializzazione Garibaldi, Catania, Italy.
⁷ Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
⁸ Massachusetts General Hospital, Boston, MA, USA.
⁹ Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
¹⁰ Royal Prince Alfred Hospital, Sydney, NSW, Australia.
¹¹ Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
¹² Northside Hospital Cancer Institute, Atlanta, GA, USA.
¹³ AC Camargo Cancer Center, São Paulo, Brazil.
¹⁴ The Angeles Clinic, Cedars Sinai Medical Center, Los Angeles, CA, USA.
¹⁵ Erasmus MC - Cancer Institute, Rotterdam, The Netherlands.
¹⁶ Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
¹⁷ Oregon Health and Science University, Portland, Oregon, USA.
¹⁸ Royal Marsden NHS Foundation Trust, London, UK.
¹⁹ Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
²⁰ Royal North Shore Hospital, St. Leonards, NSW, Australia.
²¹ The Mater Hospital, North Sydney, NSW, Australia.
²² Winship Cancer Institute, Emory University, Atlanta, GA, USA.
²³ Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
²⁴ Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
²⁵ Moffitt Cancer Center, Tampa, Florida, USA.
²⁶ Skin Oncology Division, Image Regenerative Clinic, Milan, Italy.
²⁷ University of California San Francisco (UCSF), San Francisco, CA, USA.
²⁸ Department of Otorhinolaryngology, Leiden University Medical Center, Leiden, The Netherlands.

PMID: 35426590
DOI: 10.1245/s10434-022-11622-0

Published Erratum

Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

Alexander C J van Akkooi et al. Ann Surg Oncol. 2022 Aug.

. 2022 Aug;29(8):5241-5242.

doi: 10.1245/s10434-022-11622-0.

Authors

Affiliations

¹ Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. a.v.akkooi@nki.nl.
² Mayo Clinic, Rochester, MN, USA.
³ The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
⁵ Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
⁶ Azienda di Rilievo Nazionale e di Alta Specializzazione Garibaldi, Catania, Italy.
⁷ Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
⁸ Massachusetts General Hospital, Boston, MA, USA.
⁹ Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.
¹⁰ Royal Prince Alfred Hospital, Sydney, NSW, Australia.
¹¹ Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
¹² Northside Hospital Cancer Institute, Atlanta, GA, USA.
¹³ AC Camargo Cancer Center, São Paulo, Brazil.
¹⁴ The Angeles Clinic, Cedars Sinai Medical Center, Los Angeles, CA, USA.
¹⁵ Erasmus MC - Cancer Institute, Rotterdam, The Netherlands.
¹⁶ Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
¹⁷ Oregon Health and Science University, Portland, Oregon, USA.
¹⁸ Royal Marsden NHS Foundation Trust, London, UK.
¹⁹ Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
²⁰ Royal North Shore Hospital, St. Leonards, NSW, Australia.
²¹ The Mater Hospital, North Sydney, NSW, Australia.
²² Winship Cancer Institute, Emory University, Atlanta, GA, USA.
²³ Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
²⁴ Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
²⁵ Moffitt Cancer Center, Tampa, Florida, USA.
²⁶ Skin Oncology Division, Image Regenerative Clinic, Milan, Italy.
²⁷ University of California San Francisco (UCSF), San Francisco, CA, USA.
²⁸ Department of Otorhinolaryngology, Leiden University Medical Center, Leiden, The Netherlands.

PMID: 35426590
DOI: 10.1245/s10434-022-11622-0

No abstract available

PubMed Disclaimer

Erratum for

Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
van Akkooi ACJ, Hieken TJ, Burton EM, Ariyan C, Ascierto PA, Asero SVMA, Blank CU, Block MS, Boland GM, Caraco C, Chng S, Davidson BS, Duprat Neto JP, Faries MB, Gershenwald JE, Grunhagen DJ, Gyorki DE, Han D, Hayes AJ, van Houdt WJ, Karakousis GC, Klop WMC, Long GV, Lowe MC, Menzies AM, Olofsson Bagge R, Pennington TE, Rutkowski P, Saw RPM, Scolyer RA, Shannon KF, Sondak VK, Tawbi H, Testori AAE, Tetzlaff MT, Thompson JF, Zager JS, Zuur CL, Wargo JA, Spillane AJ, Ross MI; International Neoadjuvant Melanoma Consortium (INMC). van Akkooi ACJ, et al. Ann Surg Oncol. 2022 Jun;29(6):3694-3708. doi: 10.1245/s10434-021-11236-y. Epub 2022 Jan 28. Ann Surg Oncol. 2022. PMID: 35089452

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

Affiliations

Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources